2025. Cardiovascular Adverse Event Risk in Rheumatoid Arthritis Patients Treated with JAK Inhibitor Tofacitinib versus TNF Inhibitors: a Systematic Review, Meta Analysis, and Meta Regression. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia. (Dec. 2025), 4. DOI:https://doi.org/10.53366/jimki.vi.949.